Modulation of the Immune Response in Patients With Pancreatic Tubular Adenocarcinoma

Summary

Interventional study of modulation of immune response in patients with pancreatic tubular adenocarcinoma after resection and gemcitabine treatment. When included, patients are pre-treated with moderate doses of cyclophosphamide. Then infusions of allogeneic mononuclear cells are given.

Timeline

Start

2009-04

Primary completion

2011-12

Completion

2012-12

Drugs

Indications